Abiopharma

🔍 ALBER LAURA (Director)

Company: WILLIAMS SONOMA INC (WSM)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Acquired 311,719 shares of Common Stock (Direct)
  Date: 2026-03-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,098,256.00 | transaction_form_type: 4
• Sold 157,762 shares of Common Stock at $178.42 per share (Direct)
  Date: 2026-03-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 940,494.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 18,274 shares of Common Stock (Direct)
  Date: 2026-03-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 958,768.00 | transaction_form_type: 4
• Sold 9,298 shares of Common Stock at $178.42 per share (Direct)
  Date: 2026-03-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 949,470.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 25,192 shares of Common Stock (Direct)
  Date: 2026-03-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 974,662.00 | transaction_form_type: 4
• Sold 12,818 shares of Common Stock at $178.42 per share (Direct)
  Date: 2026-03-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 961,844.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 11,178 shares of Common Stock (Direct)
  Date: 2026-03-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 973,022.00 | transaction_form_type: 4
• Sold 5,688 shares of Common Stock at $178.42 per share (Direct)
  Date: 2026-03-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 967,334.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: By Managed Account | shares_owned_after: 33,810.00 | Footnotes: F2
• Acquired 311,719 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 311,719.00 | transaction_form_type: 4 | Footnotes: F3, F4, F5
• Sold 311,719 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-21 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4, F5
• Sold 18,274 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-21 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F6, F5
• Sold 25,192 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 25,194.00 | transaction_form_type: 4 | Footnotes: F3, F7, F5
• Sold 11,178 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 22,354.00 | transaction_form_type: 4 | Footnotes: F3, F8, F5

Footnotes:

• F1: Represents the number of shares withheld upon vesting of restricted stock units to cover tax withholding obligations.
• F2: Represents the number of shares held by the reporting person in the Williams-Sonoma, Inc. Stock Fund under the Williams-Sonoma, Inc. 401(k) Plan, based on a statement dated March 22, 2026.
• F3: Each restricted stock unit represents a contingent right to receive one share of WSM common stock.
• F4: Represents restricted stock units granted on March 21, 2023, which reflect the satisfaction of performance metrics. The restricted stock units were also subject to a continued service condition, which was satisfied on March 21, 2026.
• F5: The restricted stock units are cancelled upon vesting and delivery of shares of WSM common stock.
• F6: The restricted stock units vest in four equal installments on each anniversary of the grant date in 2023, 2024, 2025 and 2026.
• F7: The restricted stock units vest in four equal installments on each anniversary of the grant date in 2024, 2025, 2026, and 2027.
• F8: The restricted stock units vest in four equal installments on each anniversary of the grant date in 2025, 2026, 2027 and 2028.